Indonesian Advertising Council Opposes Government Tobacco Ad Ban

Regulations by 2FIRSTS.ai
May.28.2024
Indonesian Advertising Council Opposes Government Tobacco Ad Ban
Opposition to Indonesian government's tobacco advertising ban law is voiced by Advertising Council DPI on May 28th.

According to Indonesian media KOMPAS on May 28, the Indonesian Advertising Council (DPI) has expressed opposition to the government's proposed health bill (RPP) that bans advertising, promotion, and sponsorship of tobacco products including cigarettes. This bill is based on Health Law No. 17 of 2023.

 

M Rafiq, the chairman of the Indonesian Public Health Association (DPI), has expressed his desire to participate in discussions regarding the draft law with the National Palace and Ministry of Health, but the government has not responded to his request. Rafiq stated at a press conference in southern Jakarta that he hopes Indonesian President Joko Widodo can review the part of the health law that prohibits the advertising, promotion, and sponsorship of tobacco products.

 

He also stated that he does not want the government to implement this regulation without the involvement of representatives from the advertising and creative industry in DPI. He warned that if this controversial plan is put into effect, it could hinder the development of the creative industry, especially under the strong commitments of President Prabowo and Vice President Gibran.

 

Rafiq emphasized that cigarette advertising has been regulated in various provisions, including the Broadcasting Act No. 32 of 2002 and the broadcasting behavior guidelines and program standards set by the Indonesian Broadcasting Commission (KPI). Additionally, Government Regulation No. 109 of 2012 ensures that manufacturers' communication is targeted only at adult consumers (18 years and older).

 

He called for attention to the development of the creative industry, emphasizing that they strictly adhere to all regulations and laws, including the Indonesian Advertising Ethics (EPI). Rafiq warned that before the COVID-19 pandemic, the creative industry had one million employees, but after the pandemic there were only 750,000 remaining. If regulations prohibiting tobacco advertising, promotion, and sponsorship are implemented, the number of tech workers may further decrease.

 

He also expressed that if the health bill is passed, the television industry would lose approximately 9 trillion Indonesian rupiahs in revenue each year due to the inability to collaborate with cigarette companies. He added that the broadcasting industry would also lose a significant portion of the advertising market, and partners of the Indonesian Digital Association and Indonesian advertising companies would also be affected.

 

The government is currently discussing the drafting of a health bill (RPP Health) or subordinate regulations in accordance with the detailed provisions of Health Law No. 17 of 2023 (UU). It is understood that the bill will include some provisions to control tobacco production, sale, and sponsorship. However, this may pose a threat to the tobacco industry (IHT). At the end of last year, the Indonesian Ministry of Economic Affairs stated that the drafting of the Health Law (RPP Kesehatan) is still under discussion, especially regarding the management of addictive substances, where a specific agreement has not yet been reached.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

U.S. Fifth Circuit Vacates NicQuid Vape MDO, Says FDA Comparative-Efficacy Standard Violated APA Procedures
U.S. Fifth Circuit Vacates NicQuid Vape MDO, Says FDA Comparative-Efficacy Standard Violated APA Procedures
According to VitalLaw on August 27, 2026, the U.S. Court of Appeals for the Fifth Circuit vacated an FDA marketing denial order (MDO) against NicQuid LLC, ruling that the agency’s comparative-efficacy standard for electronic nicotine delivery system (ENDS) applications had become a substantive rule requiring notice-and-comment rulemaking under the Administrative Procedure Act (APA). The court did not reject FDA’s authority to compare the public health benefits and risks of flavored vapes, but held that the agency could not establish a broadly binding standard through informal adjudications. The case was remanded to FDA for further proceedings.
Aug.28
BAT Expands ITC Infotech Partnership Across Poland, Romania and India to Advance AI
BAT Expands ITC Infotech Partnership Across Poland, Romania and India to Advance AI
ITC Infotech has expanded its multi-year strategic technology partnership with British American Tobacco (BAT), providing technology services across Poland, Romania and India while continuing to support BAT's newly launched Future Capabilities Centre in India and existing technology hubs in Malaysia and Mexico. The companies said the agreement will focus on AI-enabled innovation, technology capability building and greater operational efficiency. The partnership also aligns with BAT's broader Fit2Win transformation programme, under which the group is expanding the use of external technology and business-services partners to simplify its global operating model.
Aug.13
New York’s 75% Wholesale Tax on Nicotine Pouches Takes Effect Sept. 1, With Aug. 31 Inventory Subject to Floor Tax
New York’s 75% Wholesale Tax on Nicotine Pouches Takes Effect Sept. 1, With Aug. 31 Inventory Subject to Floor Tax
New York State will extend its tobacco products tax to “alternative nicotine products,” including tobacco-free nicotine pouches, from September 1, 2026, at a rate of 75% of the wholesale price. Distributors, wholesalers and retailers must also inventory products held as of 11:59 p.m. on August 31 and pay a floor tax. Vapor products are excluded from the new category and remain subject to New York's separate 20% supplemental sales tax on the retail price.
Aug.26
FDA Unifies Tobacco Registration and Product Listing Form Across Product Categories
FDA Unifies Tobacco Registration and Product Listing Form Across Product Categories
The U.S. FDA has consolidated two tobacco establishment registration and product listing forms into a redesigned Form FDA 3741 covering all regulated product categories, including e-cigarettes, heated tobacco products and nicotine pouches. The current requirements remain limited to domestic establishments. Separately, the FDA has proposed extending registration and product listing requirements to foreign manufacturers, signaling greater regulatory attention to manufacturing entities and product-level information across the tobacco and nicotine supply chain.
FDA
Sep.30
Germany's Four-Year Tobacco Tax Plan Heads to Parliament as BAT, JTI and PMI Push for Changes
Germany's Four-Year Tobacco Tax Plan Heads to Parliament as BAT, JTI and PMI Push for Changes
Germany's parliament is scheduled to hold a first reading of amendments to the Tobacco Tax Act on September 24. The government plans annual tax increases from 2027 through 2030 covering cigarettes, heated tobacco, vaping liquids and other categories. It expects the reform to generate €756 million in additional revenue in 2027, rising to €3.589 billion in additional annual revenue by 2030. Ahead of the parliamentary debate, the German Association of the Tobacco Industry and Novel Products, or BVTE, launched the "Tabaksteuer mit Augenmaß" campaign backed by BAT, JTI, Philip Morris, Reemtsma and wholesale and retail groups.
Sep.23
JTI Invests ₱2.1 Billion to Upgrade Batangas Manufacturing Hub, Adds First Southeast Asia DIET Facility
JTI Invests ₱2.1 Billion to Upgrade Batangas Manufacturing Hub, Adds First Southeast Asia DIET Facility
JTI Asia Manufacturing Corp. has invested ₱2.1 billion, or about $37 million, in its manufacturing site in Malvar, Batangas, Philippines, to expand tobacco-processing capabilities. About ₱1.9 billion is allocated to JTI's first Dry Ice Expanded Tobacco, or DIET, facility in Southeast Asia, while more than ₱177 million has been spent on expanding its Controlled Atmosphere treatment facility. The Batangas plant supplies the Philippine market and exports to 22 overseas markets, making it one of JTI's key manufacturing hubs in Asia.
Sep.24